Ameril, Baby Girl .
HRN: 25-09-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/16/2025
03/22/2025
IV
300 Mg
Q6H
Measles Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes